Veeda Scientific Analysis has acquired a major minority stake in Bioneeds, a preclinical CRO primarily based in Bangalore.
Veeda will search to additional enhance its stake in Bioneeds within the close to time period. Veeda’s funding in Bioneeds comes shortly after its launch of Ingenuity BioSciences an innovation-centric bioanalytical laboratory for biosimilars, in three way partnership with Somru BioScience, a Canadian biotechnology firm.
Talking on the event, Ajay Tandon, Managing Director, Veeda stated, “Veeda aspires to be the analysis accomplice of alternative for modern (bio)pharmaceutical corporations worldwide by supporting their essential product improvement programmes with a complete portfolio of providers spanning pre-clinical, medical and bio analytical analysis. We’re delighted to see our partnership with Bioneeds come to fruition and stay up for collaborating with Dr Vinaya Babu and his crew of extremely certified professionals to serve our world clientele. We consider that the mixed platform will leverage the numerous adjacencies and synergies in our capabilities to seamlessly ship built-in programmes below a standard umbrella.”
Dr Vinaya Babu, Founder and Managing Director Bioneeds, stated, “Partnering with Veeda is a logical ahead integration of the invention and regulatory functionality and therefore the mixed platform makes one cease answer for to pharma, biopharma, medical system and chemical industries from discovery to market”.